Search

Search Results

• 

  Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience

  Roberto Giulianelli, Barbara Cristina Gentile, Gabriella Mirabile, Luca Albanesi, Paola Tariciotti, Giorgio Rizzo, Maurizio Buscarini, Mauro Vermiglio

  272-276

  2017-12-31

  Published: December 31, 2017

  1452

  PDF: 767
• 

  How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice

  Aldo Franco De Rose, Francesco Vecco, Francesca Ambrosini, Rafaela Malinaric, Guglielmo Mantica, Carlo Terrone

  369-370

  2022-09-26

  Published: September 26, 2022

  565

  PDF: 289
• 

  Adverse pathological outcomes of patients with de novo muscle invasive bladder cancer in Northern Ontario

  Vahid Mehrnoush, Shahrzad Keramati, Asmaa Ismail, Waleed Shabana, Ahmed Zakaria, Hazem Elmansy, Walid Shahrour, Owen Prowse, Ahmed Kotb

  41-45

  2022-03-29

  Published: March 29, 2022

  1061

  PDF: 347